Does the use of cannabis increase the risk for psychosis and the development of schizophrenia?;Eykur notkun kannabis hættu á gedrofi og próun gedklofa?

Laeknabladid

Volumn 100, Issue 9, 2014, Pages 443-451

  Jónsson, Arnar Jan ^a   Birgisdóttir, Hera ^a   Sigurdsson, Engilbert ^a,b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Association; Cannabis; Psychosis; Schizophrenia

Indexed keywords

AGE; CANNABIS ADDICTION; CANNABIS SMOKING; DOSE RESPONSE; HUMAN; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PSYCHOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; TIME;

AGE FACTORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MARIJUANA ABUSE; MARIJUANA SMOKING; PSYCHOTIC DISORDERS; RISK ASSESSMENT; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS;

EID: 84906971636     PISSN: 00237213     EISSN: 16704959     Source Type: Journal    
DOI: 10.17992/lbl.2014.09.556     Document Type: Article

References (50)

1. Organization WH. Management of substance abuse 2013. who.int/substance-Abuse/facts/cannabis/en/-Apríl 2014.
2. Vímuefnaneysla unglinga í efstu bekkjum grunnskóla á Íslandi: próun frá 1997 til 2012: Rannsóknir og greining, Háskólinn í Reykjavík 2012.
3. Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 2001; 178: 101-6.
4. Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987; 2: 1483-6.
5. Degenhardt L, Hall W. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med 2001; 31: 659-68.
6. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997; 54: 313-21.
7. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264: 2511-8.
8. Andreasson S, Allebeck P, Rydberg U. Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiatr Scand 1989; 79: 505-10.
9. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002; 325: 1199.
10. Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Andreasson S, Allebeck P. Cannabis, schizophrenia and other non-Affective psychoses: 35 years of follow-up of a population-based cohort. Psychol Med 2012; 42: 1321-8.
11. Eaton WW, Regier DA, Locke BZ, Taube CA. The Epidemiologic Catchment Area Program of the National Institute of Mental Health. Public Health Rep 1981; 96: 319-25.
12. Tien AY, Anthony JC. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. J Nerv Ment Dis 1990; 178: 473-80.
13. van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal populationbased study. Am J Epidemiol 2002; 156: 319-27.
14. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002; 325: 1212-3.
15. Yung AR, McGorry PD, Francey SM, Nelson B, Baker K, Phillips LJ, et al. PACE: a specialised service for young people at risk of psychotic disorders. Med J Aust 2007; 187: S43-6.
16. Phillips LJ, Curry C, Yung AR, Yuen HP, Adlard S, McGorry PD. Cannabis use is not associated with the development of psychosis in an 'ultra' high-risk group. Aust N Z J Psychiatry 2002; 36: 800-6.
17. Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychol Med 2003; 33: 15-21.
18. Fergusson DM, Horwood LJ, Ridder EM. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 2005; 100: 354-66.
19. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005; 330: 11.
20. Kuepper R, van Os J, Lieb R, Wittchen HU, Hofler M, Henquet C. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ 2011; 342: d738.
21. Singleton N, Bumpstead R, O'Brien M, Lee A, Meltzer H. Psychiatric morbidity among adults living in private households, 2000 (Reprinted from Psychiatric morbidity among adults living in private households, 2000: Summary report, 2001). Int Rev Psychiatry 2003; 15: 65-73.
22. Wiles NJ, Zammit S, Bebbington P, Singleton N, Meltzer H, Lewis G. Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. Br J Psychiatry 2006; 188: 519-26.
23. Najman JM, Bor W, O'Callaghan M, Williams GM, Aird R, Shuttlewood G. Cohort Profile: The Mater-University of Queensland Study of Pregnancy (MUSP). Int J Epidemiol 2005; 34: 992-7.
24. McGrath J, Welham J, Scott J, Varghese D, Degenhardt L, Hayatbakhsh MR, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry 2010; 67: 440-7.
25. Rolfe M, Tang CM, Sabally S, Todd JE, Sam EB, Hatib N'Jie AB. Psychosis and cannabis abuse in The Gambia. A casecontrol study. Br J Psychiatry 1993; 163: 798-801.
26. Grech A, Takei N, Murray RM. Comparison of cannabis use in psychotic patients and controls in London and Malta. Schizophr Res 1998; 29: 22.
27. Degenhardt L, Hall W. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med 2001; 31: 659-68.
28. Miller P, Lawrie SM, Hodges A, Clafferty R, Cosway R, Johnstone EC. Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2001; 36: 338-42.
29. Farrell M, Boys A, Bebbington P, Brugha T, Coid J, Jenkins R, et al. Psychosis and drug dependence: results from a national survey of prisoners. Br J Psychiatry 2002; 181: 393-8.
30. Agosti V, Nunes E, Levin F. Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence. Am J Drug Alcohol Abuse 2002; 28: 643-52.
31. Stefanis NC, Delespaul P, Henquet C, Bakoula C, Stefanis CN, Van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004; 99: 1333-41.
32. Sevy S, Robinson DG, Napolitano B, Patel RC, Gunduz-Bruce H, Miller R, et al. Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia. Schizophr Res 2010; 120: 101-7.
33. Dragt S, Nieman DH, Schultze-Lutter F, van der Meer F, Becker H, de Haan L, et al. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatr Scand 2012; 125: 45-53.
34. Dixon L, Haas G, Weiden P, Sweeney J, Frances A. Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophr Bull 1990; 16: 69-79.
35. Peralta V, Cuesta MJ. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr Scand 1992; 85: 127-30.
36. Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RSE, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A 2012; 109: E2657-E64.
37. Solowij N, Stephens RS, Roffman RA, Babor T, Kadden R, Miller M, et al. Cognitive functioning of long-Term heavy cannabis users seeking treatment. JAMA 2002; 287: 1123-31.
38. Glass M, Dragunow M, Faull RLM. Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997; 77: 299-318.
39. Laviolette SR, Grace AA. The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction. Cell Mol Life Sci 2006; 63: 1597-613.
40. Kirkbride J. The risk of substance-induced psychosis converting to schizophrenia varies with substance used and patient age. Evid Based Ment Health 2013; 16: 65.
41. Johns LC, van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev 2001; 21: 1125-41.
42. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-Analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 2009; 39: 179-95.
43. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319-28.
44. Large M, Sharma S, Compton MT, Slade T, Nielssen O. Cannabis Use and Earlier Onset of Psychosis. Arch Gen Psychiatry 2011; 68: 555-61.
45. Degenhardt L, Hall W, Lynskey M. Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend 2003; 71: 37-48.
46. van Os J, Hanssen M, Bijl RV, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: an urban-rural comparison. Arch Gen Psychiatry 2001; 58: 663-8.
47. Verdoux H, Maurice-Tison S, Gay B, Van Os J, Salamon R, Bourgeois ML. A survey of delusional ideation in primarycare patients. Psychol Med 1998; 28: 127-34.
48. Pijlman FT, Rigter SM, Hoek J, Goldschmidt HM, Niesink RJ. Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops. Addict Biol 2005; 10: 171-80.
49. Vindenes V, Strand DH, Kristoffersen L, Boix F, Morland J. Has the intake of THC by cannabis users changed over the last decade? Evidence of increased exposure by analysis of blood THC concentrations in impaired drivers. Forensic Sci Int 2013; 226: 197-201.
50. Volkov ND, Baler RD, Compton WN, Weiss SRB. Adverse health effects of marijuana use. N Engl J Med 2014; 370: 2219-27.